Boston Scientific Inc. (BSX): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.3%. By the end of trading, Boston Scientific rose $0.22 (1.9%) to $11.67 on light volume. Throughout the day, 11,541,774 shares of Boston Scientific exchanged hands as compared to its average daily volume of 16,182,300 shares. The stock ranged in a price between $11.44-$11.69 after having opened the day at $11.45 as compared to the previous trading day's close of $11.45. Other companies within the Health Services industry that increased today were: Vision-Sciences Inc (DE ( VSCI), up 9.0%, Escalon Medical Corporation ( ESMC), up 6.4%, DexCom ( DXCM), up 6.2% and Cardica ( CRDC), up 5.8%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.4 billion and is part of the health care sector. Shares are up 100.0% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance, expanding profit margins, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Allied Healthcare Products ( AHPI), down 5.4%, BioScrip ( BIOS), down 4.5%, Pro-Dex ( PDEX), down 4.3% and Hooper Holmes ( HH), down 4.2%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.